Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

featured

Published in Obesity, Metabolic Syndrome, and Prediabetes

Expert Opinion / Cases · September 03, 2018

Patient With h/o Gestational Diabetes Now Has Poor Glycemic Control

Written by

Silvio E. Inzucchi MD

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Additional Info

Disclosures

Disclosure statements are available on the authors' profiles:

Silvio Inzucchi MD

Discuss This item Follow

Satish Tiwari

Oct 24, 2018

Upto how much time insulin can be given in GDM

Folasade lawal

Jun 11, 2019

Thanks for having me.  
Is it possible she undergoes self blood sugar monitoring called 360 degree view 3-day profile? 
This might help to see how her insulin dose and food affect her blood sugar

Chidiebere Valentine

Apr 02, 2020

Strategies to improve glycemic control:1. addition of metformin which improves insulin resistance in PCOS. 2. Addition of thiazolidinediones such as pioglitazone will improve glycemic control and also to treat NASH

Nov 24, 2024

Pending Moderator approval.
Delete

Obesity, Metabolic Syndrome, and Prediabetes

Patient With h/o Gestational Diabetes Now Has Poor Glycemic Control

Additional Info

Discuss This item Follow

Satish Tiwari

Folasade lawal

Chidiebere Valentine

Further Reading

Once-Weekly Semaglutide in Individuals With Obesity and Knee Osteoarthritis

Associations of Diabetes and Prediabetes With Mortality and Life Expectancy in Chinese Individuals

The Burden of Diabetes-Associated Multiple Long-Term Conditions on Years of Life Spent and Lost

Impact of GLP-1 Receptor Agonist–Based Treatments on Fat-Free Mass

Association Between Ultraprocessed Food Consumption and the Risk of Diabetes

Association of Glycaemic Risk Factors and Diabetes Duration With the Risk of Heart Failure in People With Type 2 Diabetes

Outcomes of Time-Restricted Eating in Adults With Metabolic Syndrome

Impact of Overweight and Obesity on Health Outcomes in the US From 1990 to 2021

The Effect of Semaglutide on Mortality and COVID-19–Related Deaths

Impact of GLP-1 RAs on Cardiorenal Outcomes and Mortality in People With Type 2 Diabetes and Acute Kidney Disease

SGLT2 Inhibitors in Hospitalised Patients With COVID-19

Recently Updated